TREATMENT METHOD FOR KIDNEY TRANSPLANT REJECTIONDisclosed is a method for treating or preventing kidney transplantation rejection in a patient by administering to the patient autologous, ex vivo-modified and expanded CD4CD25Foxp3CD127T reg cells.Svetlana N. BYKOVSKAIA...
[Treatment of kidney graft rejection with a monoclonal antibody (Orthoclone OKT-3)] 来自 NCBI 喜欢 0 阅读量: 11 作者:SD Ladefoged,M Friedberg,A Glenthj 摘要: Polyclonal syngeneic, allogeneic. and xenogeneic and monoclonal syngeneic anti-anii-idiotypic antibodies have been produced against ...
EXTRACORPOREAL PHOTOAFERESIS: AN ALTERNATIVE TREATMENT FOR REFRACTORY KIDNEY REJECTION Electronic Journal of BiomedicineMusso, Carlos G.Enz, Paula A.
The prevalence of kidney diseases is emerging as a public health problem. Stem cells (SCs), currently considered as a promising tool for therapeutic application, have aroused considerable interest and expectations. With self-renewal capabilities and grea
The prevalence of kidney diseases is emerging as a public health problem. Stem cells (SCs), currently considered as a promising tool for therapeutic application, have aroused considerable interest and expectations. With self-renewal capabilities and grea
Kidney transplant recipients with BK virus nephropathy or viremia are generally treated with reduction of immunosuppression to facilitate virus eradication.Prompted by biopsy findings interpreted as acute rejection, we administered intravenous bolus steroids to five patients with BK virus in the plasma (BKP...
A major hurdle to improving clinical care in kidney transplantation is the lack of biomarkers of the response to antibody-mediated rejection (ABMR) treatment. We investigated the role of C1q-binding donor-specific anti-HLA antibodies (DSAs) in defining the response to standard of care ...
Combined Therapy of Deoxyspergualin and Plasmapheresis: A Useful Treatment for Antibody-Mediated Acute Rejection After Kidney Transplantation Antibody-mediated acute rejection (AbAR) is one of the primary causes of graft impairment in kidney transplant recipients. Deoxyspergualin (DSG), which dis......
Everolimus, a mammalian target of rapamycin (mTOR) inhibitor, has been used in acute and chronic treatment of kidney and heart transplants. There is scarce... T Casanovas,A Argudo,MC Pe?A-Cala - 《Transplant Proc》 被引量: 32发表: 2011年 Liver transplantation for hepatocellular carcinoma He...
Treatment Options for Anemia in Kidney Transplant Patients: A Review Anemia is common after kidney transplantation. The etiology may be multifactorial, such as causes of anemia in the general population and causes that are u... M Bonomini,LD Liberato,V Sirolli - 《Kidney Medicine》 被引量: 0...